ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
135 hedge funds and large institutions have $893M invested in Alder Biopharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 140 → 135 (-5)
93% less call options, than puts
Call options by funds: $1.06M | Put options by funds: $16M
Holders
135
Holding in Top 10
5
Calls
$1.06M
Puts
$16M
Top Buyers
| 1 | +$31.7M | |
| 2 | +$17.4M | |
| 3 | +$13.6M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$12M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$11M |
Top Sellers
| 1 | -$26.8M | |
| 2 | -$21.3M | |
| 3 | -$16.5M | |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$7.72M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.02M |